Page 2 - David Essam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perfect drug, but in a very modest way it— perfect drug, but in a very modest way it can — perfect drug, but in a very modest way it can slow the decline from alzheimer's. so even though it is very modest, that is highly significant.— very modest, that is highly siunificant. �* , significant. and they say is an international _ significant. and they say is an international story _ significant. and they say is an international story in - significant. and they say is an international story in lots - significant. and they say is an international story in lots of l significant. and they say...

Is a significant moment in the fight against alzheimer's. fergus walsh, bbc news. we're joined now by susan kohlhaas, director of research at alzheimer's research uk. morning to you. lots of people watching this morning will see this story, see the headline and then, at last, something. haifa story, see the headline and then, at last, something.— last, something. how positive is this? this _ last, something. how positive is this? this is _ last, something. how positive is this? this is an _ last, something. how positive is this? this is an historic - last, something. how positive is this? th...

The symptoms of cognitive impairment and also the behavioural- symptoms associated - with alzheimer's disease. david and his wife cheryl can't be sure if the drug is making a difference, but they're delighted to have taken part in the trial. when we first began this two and a half years ago, we didn't necessarily think it would help us, but we felt we were doing something and could help future generations. it's just a horrible, nasty thing because if you... if you... if somebody can slow it down, and then eventually get it stopped altogether, you know, it'd be brilliant. at least half a millio...

In memory and understanding. david is one of nearly 2,000 patients who took part in a major trial of a new drug — lecanemab. as normal, if you just - lift your arm up there for me. it involved having an infusion every two weeks. lecanemab didn't stop alzheimer's... i'lljust get you started here. ..but over 18 months, it's slowed its progression by about a quarter. this is so exciting because now we're getting results, - the first results that - are indicating that the drug is successfully treating _ the underlying cause and is slowing down the symptoms of cognitive impairment, and also— th...

No, it's not. so, some of those who took— no, it's not. so, some of those who took part— no, it's not. so, some of those who took part suffered brain swelling and also — took part suffered brain swelling and also bleeds in the brain. so patients— and also bleeds in the brain. so patients need to be carefully monitored. but i can tell you that the patients i might like david, and another— the patients i might like david, and another couple, who didn't know whether— another couple, who didn't know whether they were on the drug initially, — whether they were on the drug initially, o...